Kevin’s mind relied on familiar pathways built by years of playing and coaching basketball. He used his analytical skills to ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

From bipolar disorder to hepatitis, and from strokes to development of magnetic resonance imaging, research tied to NIH ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...

Chronic lymphocytic leukemia (CLL ... rates of leukemia — particularly acute myeloid leukemia — are higher in workers exposed to high levels of benzene. Benzene is used in industries such ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...